Continuous glucose monitor study for seafarers with diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests if wearing a continuous glucose monitor (CGM) for 12 months helps seafarers on insulin better manage their blood sugar levels while at sea. You'll also use an app to log readings and activities.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a seafarer who needs insulin to control your diabetes.
- You have a valid ML5 or ENG1 medical certificate.
- You can wear a continuous glucose monitor (a small sensor on your skin) for 12 months.
- You are able to use a smartphone app to track your blood sugar readings and activities while at sea.
- You are of any ethnicity.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new continuous glucose monitor (CGM) that you wear for 14 days. It checks how accurate the device is and how well it helps track your blood sugar levels, all while being safe and easy to use.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
This study tests whether wearing a continuous glucose monitor (a small sensor on your skin that tracks your blood sugar) can help people with prediabetes and obesity better control their blood sugar and lose weight. You will be asked to wear the device for several days to see how your glucose levels change throughout the day.
This study tests whether using a continuous glucose monitor (CGM) helps people who were just diagnosed with type 2 diabetes manage their blood sugar better. Participants wear a small sensor on their arm that checks sugar levels all the time.
This trial tests if using a continuous glucose monitor (CGM) helps older adults with type 2 diabetes who are not on insulin to better control their blood sugar. The results will show if CGM is a helpful tool for managing diabetes without daily shots.
This study asks people with diabetes to use a continuous glucose monitor (a small device that tracks blood sugar automatically) and share their thoughts about it. Researchers want to understand what features matter most to patients and how well the device works in real life.
Hear when a new Insulin Dependent Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.